Ignite Creation Date:
2024-05-06 @ 2:21 AM
Last Modification Date:
2024-10-26 @ 11:17 AM
Study NCT ID:
NCT02023671
Status:
UNKNOWN
Last Update Posted:
2013-12-30
First Post:
2013-12-24
Brief Title:
IMMUNOPHENOTYPE ROLE IN THE EVALUATION OF CLINICAL RESPONSE
Sponsor:
Azienda Ospedaliera San Giovanni Battista
Organization:
Azienda Ospedaliera San Giovanni Battista
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2013-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study proposed by SSCVD Allogeneic Stem Cells of this Hospital provides for the collection of a series composed of patients with multiple myeloma undergoing allogeneic stem cell transplants at our center in the period 2000-2011
This collection is carried out with retrospective investigation through the review of paper and electronic records and data cards already collected as part of clinical trials conducted by our own Division and approved by the Ethics Committee of Management
The purpose of data collection is particularly retrospective analysis of the incidence of extramedullary relapse the response in flow cytometry immunophenotypic and clinical response of the disease will also be taken into consideration for overall survival OS event-free survival EFS the cumulative incidence of treatment-related mortality and graft- versus-host disease GVHD acute and chronic
The data were processed in a completely anonymous and as provided by law The results of the study will not result in any diagnostic or therapeutic intervention on patients still alive
This collection is carried out with retrospective investigation through the review of paper and electronic records and data cards already collected as part of clinical trials conducted by our own Division and approved by the Ethics Committee of Management
The purpose of data collection is particularly retrospective analysis of the incidence of extramedullary relapse the response in flow cytometry immunophenotypic and clinical response of the disease will also be taken into consideration for overall survival OS event-free survival EFS the cumulative incidence of treatment-related mortality and graft- versus-host disease GVHD acute and chronic
The data were processed in a completely anonymous and as provided by law The results of the study will not result in any diagnostic or therapeutic intervention on patients still alive
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None